These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2958719)

  • 1. Examination of the relationship between the uptake site for 5-hydroxytryptamine and the high affinity binding site for [3H]imipramine. II. The role of sodium ions.
    Wood MD
    Neuropharmacology; 1987 Aug; 26(8):1081-5. PubMed ID: 2958719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of the relationship between the uptake system for 5-hydroxytryptamine and the high-affinity [3H]imipramine binding site--I. Inhibition by drugs.
    Wood MD; Broadhurst AM; Wyllie MG
    Neuropharmacology; 1986 May; 25(5):519-25. PubMed ID: 3016589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unaltered 5-HT- and desipramine-sensitive [3H]imipramine binding and [3H]5-HT uptake in rat brain after chronic imipramine and norzimeldine treatment.
    Marcusson J; Bäckström IT; Ross SB
    Psychopharmacology (Berl); 1988; 94(2):193-6. PubMed ID: 2965397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
    Marcusson JO; Bäckström IT; Ross SB
    Mol Pharmacol; 1986 Aug; 30(2):121-8. PubMed ID: 3016498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by tetanus toxin of sodium-dependent, high-affinity [3H]5-hydroxytryptamine uptake in rat synaptosomes.
    Inserte J; Najib A; Pelliccioni P; Gil C; Aguilera J
    Biochem Pharmacol; 1999 Jan; 57(1):111-20. PubMed ID: 9920291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes induced by corticosterone and adrenalectomy in synaptosomal and platelet uptake and binding of 5-HT. The relationship to [3H]imipramine binding.
    Lee PH; Chan MY
    Neuropharmacology; 1985 Nov; 24(11):1043-50. PubMed ID: 4080103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of high- and low-affinity [3H]imipramine recognition sites in rat brain by chronic treatment with antidepressants.
    Hrdina PD
    Eur J Pharmacol; 1987 Jun; 138(2):159-68. PubMed ID: 3040430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-affinity binding of [3H]imipramine to primary astrocyte cultures.
    Waniewski RA; Katz DM; Kimelberg HK
    Biochem Pharmacol; 1987 Mar; 36(5):639-46. PubMed ID: 3827948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subdivision of mouse brain [3H]imipramine binding based on ion dependence and serotonin sensitivity.
    Severson JA; Woodward JJ; Wilcox RE
    J Neurochem; 1986 Jun; 46(6):1743-54. PubMed ID: 3701330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation kinetics of [3H]paroxetine binding to rat brain consistent with a single-site model of the antidepressant binding/5-hydroxytryptamine uptake site.
    Marcusson J; Eriksson K
    J Neurochem; 1988 Nov; 51(5):1477-81. PubMed ID: 2971784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation between the binding of 3H-imipramine and the uptake of catecholamines in synaptosomal preparations of the rat brain after chronic treatment with imipramine].
    Dagonneau H; Fonlupt P; Pacheco H
    C R Seances Soc Biol Fil; 1984; 178(1):38-44. PubMed ID: 6331605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of [3H]paroxetine binding in rat brain.
    Marcusson JO; Bergström M; Eriksson K; Ross SB
    J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity binding of [3H]desipramine to rat brain: a presynaptic marker for noradrenergic uptake sites.
    Rehavi M; Skolnick P; Brownstein MJ; Paul SM
    J Neurochem; 1982 Apr; 38(4):889-95. PubMed ID: 7062040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The existence on the serotonin carrier of 2 independent sites for the specific binding of trazodone and imizin].
    Katanasov AB; Brusov OS
    Farmakol Toksikol; 1988; 51(6):32-5. PubMed ID: 2976683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoxetine-induced inhibition of synaptosomal [3H]5-HT release: possible Ca(2+)-channel inhibition.
    Stauderman KA; Gandhi VC; Jones DJ
    Life Sci; 1992; 50(26):2125-38. PubMed ID: 1608295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium-dependent [3H]imipramine binding in rat hippocampus and its relationship to serotonin uptake.
    Hrdina PD
    Can J Physiol Pharmacol; 1987 Dec; 65(12):2422-7. PubMed ID: 2452679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panuramine, a selective inhibitor of uptake of 5-hydroxytryptamine in the brain of the rat.
    Blurton PA; Broadhurst AM; Cross JA; Ennis C; Wood MD; Wyllie MG
    Neuropharmacology; 1984 Sep; 23(9):1049-52. PubMed ID: 6514142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity of 25 paroxetine/femoxetine structure variants in various reactions, assumed to be important for the effect of antidepressants.
    Plenge P; Mellerup ET; Honoré T; Honoré PL
    J Pharm Pharmacol; 1987 Nov; 39(11):877-82. PubMed ID: 2892909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-affinity [3H]6-nitroquipazine binding to the 5-hydroxytryptamine transport system in rat lung.
    Hashimoto K; Goromaru T
    Biochem Pharmacol; 1991 Jun; 41(11):1679-82. PubMed ID: 1828346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.